BlackRock Fund Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $263M | Buy |
7,252,632
+7,226,676
| +27,842% | +$262M | 0.05% | 454 |
|
|
2016
Q3 | $1.19M | Sell |
25,956
-5,607
| -18% | -$258K | ﹤0.01% | 3217 |
|
|
2016
Q2 | $1.59M | Buy |
31,563
+3,436
| +12% | +$173K | ﹤0.01% | 3227 |
|
|
2016
Q1 | $1.51M | Sell |
28,127
-12,816
| -31% | -$686K | ﹤0.01% | 3133 |
|
|
2015
Q4 | $2.69M | Sell |
40,943
-116,446
| -74% | -$7.64M | ﹤0.01% | 3077 |
|
|
2015
Q3 | $8.89M | Sell |
157,389
-178,900
| -53% | -$10.1M | ﹤0.01% | 2445 |
|
|
2015
Q2 | $19.9M | Sell |
336,289
-33,350
| -9% | -$1.97M | ﹤0.01% | 2121 |
|
|
2015
Q1 | $23M | Buy |
369,639
+88,050
| +31% | +$5.49M | 0.01% | 1997 |
|
|
2014
Q4 | $16.2M | Buy |
281,589
+45,323
| +19% | +$2.61M | ﹤0.01% | 2181 |
|
|
2014
Q3 | $12.7M | Buy |
236,266
+77,632
| +49% | +$4.17M | ﹤0.01% | 2216 |
|
|
2014
Q2 | $8.32M | Buy |
158,634
+66,036
| +71% | +$3.46M | ﹤0.01% | 2530 |
|
|
2014
Q1 | $4.89M | Buy |
92,598
+34,400
| +59% | +$1.82M | ﹤0.01% | 2830 |
|
|
2013
Q4 | $2.33M | Buy |
58,198
+25,900
| +80% | +$1.04M | ﹤0.01% | 3119 |
|
|
2013
Q3 | $1.22M | Buy |
32,298
+4,464
| +16% | +$169K | ﹤0.01% | 3164 |
|
|
2013
Q2 | $1.09M | Buy |
+27,834
| New | +$1.09M | ﹤0.01% | 3151 |
|